Total investments received (USD): 3.8m
Round value (USD): 3.8m
Company: Nadmed
Industry:
Biotech
Health services

Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain
United Kingdom